Intermolecular IPO Advisory

IPO Research - IPO Boutique



Trade Date
Intermolecular, Inc.IMI
[ Nasdaq ]
10.009.65 millionNovember 18 2011
Morgan Stanley, J.P. Morgan, Barclays Capital
Pacific Crest Securities, Needham & Co.
3011 N. First Street, San Jose, CA, 95134, US
Intermolecular Web Site:

For IPO Boutique's "scale of 1 to 5" BUY rating on Intermolecular, Inc., and our comprehensive analysis, click the "Buy Market Research" link above.

About Intermolecular (adapted from Intermolecular prospectus):
Intermolecular, Inc. develops proprietary technology and intellectual property (IP) for their customers focused on advanced materials, processes, integration and device architectures. Their proprietary technology seeks to enable customers to bring optimized, high-volume manufacturing-ready integrated devices to market faster and with less risk than traditional approaches to R&D. Intermolecular provides customers with the developed proprietary technology through various fee arrangements and grants them rights to associated IP, primarily through royalty-bearing licenses.

Their primary focus is on large, high-volume semiconductor and high-growth emerging clean-energy markets, including DRAM, flash memory, complex logic, flat glass, solar cells, LEDs and other energy-efficient technologies with Intermolecular's HPC platform. Within these broad markets, they have engaged in paid programs for 18 customers, including ATMI, Elpida Memory, GLOBALFOUNDRIES, Guardian Industries, SanDisk, Taiwan Semiconductor Manufacturing Company (TSMC) and Toshiba. ATMI and Elpida have commenced shipping products incorporating technology developed through Intermolecular's CDPs and pay Intermolecular licensing and royalty fees. Intermolecular claims to have received the majority of their revenue from customers in DRAM, flash memory, complex logic and energy-efficient applications in flat glass, and says they have not yet received a material amount of revenue from customers in solar cells, LEDs and other energy-efficient technologies.

This description is adapted from Intermolecular prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus..

IPO Boutique aggregates information on public companies and private companies, such as Intermolecular "IMI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Need a recommendation?
Visit our Testimonials page and see over 200 investors singing our praises.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription

© 2005 - 2014 IPO Boutique. All Rights Reserved